| Date Filed | Type | Description |
| 08/17/2023 |
4
| Wilson Mark Andrew (Chief Legal Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 7,221 shares
@ $0.78, valued at
$5.6k
|
|
| 05/17/2023 |
4
| Wilson Mark Andrew (Chief Legal Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 7,543 shares
@ $0.72, valued at
$5.4k
|
|
| 11/18/2022 |
4
| Wilson Mark Andrew (Chief Legal Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 8,690 shares
@ $3.57, valued at
$31k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 3,661 shares
@ $10.95, valued at
$40.1k
|
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 20,100 shares
@ $0
Sold 6,564 shares
@ $13.16, valued at
$86.4k
|
|
| 10/14/2021 |
4
| Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 35,800 options to buy
@ $21.79, valued at
$780.1k
|
|
| 05/19/2021 |
4
| Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,917 shares
@ $18.3, valued at
$35.1k
|
|
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 28,550 shares
@ $0
Granted 51,000 options
@ $18.75, valued at
$956.3k
|
|
| 11/18/2020 |
4
| Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,539 shares
@ $16.93, valued at
$26.1k
|
|
| 08/19/2020 |
4
| Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,529 shares
@ $19.67, valued at
$30.1k
|
|
| 05/20/2020 |
4
| Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,529 shares
@ $22.51, valued at
$34.4k
|
|
| 04/08/2020 |
3
| Wilson Mark Andrew (SVP & General Counsel) has filed a Form 3 on NEKTAR THERAPEUTICS |